StockData
Scinai Immunotherapeutics Ltd. logo

Scinai Immunotherapeutics Ltd. (SCNI) stock

SCNINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 6/30
$0.37−0.01 (-1.40%)

Close on Nov 18, 2026Market cap $1.27MP/E –Yield –

Scinai Immunotherapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Scinai Immunotherapeutics's pe ratio was 6.4× on Feb 27, 2026, against 2.2× a year earlier. Over the last 3 years it ranged from 1.2× to 6.4×, with a median of 2.9×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Feb 27, 20266.4×+4.2
2025Dec 31, 20252.2×+0.2
2024Dec 31, 20242.1×+0.6
2023Dec 29, 20231.5×–

More Scinai Immunotherapeutics figures

See a number that looks wrong?